Select language

Amway reports sustained growth in 2025 in the region

2026.04.09 | Amway | Press Release

Amway, the world’s largest direct selling company[1], has released its 2025 financial results and announced key updates, confirming its global leadership in the industry, with global revenue of $7.3 billion USD[2]. In a continuously evolving environment, the ESAN region (Europe, Southern Africa, Australia and New Zealand) recorded sales of $439 million USD in 2025, a 3.5% increase from $424 million USD[4] in 2024, confirming a growth trend sustained over several years.

This increase reflects a clear and consistent strategic focus on holistic wellbeing, a deep understanding of local consumer needs, and the strength of the Amway community across its diverse markets.

 

Sustained growth across ESAN markets

The ESAN region’s 2025 results are the product of a multi-year strategy consistently executed across a geographically diverse set of markets. The growth was broad-based, with several markets posting particularly strong year-on-year performances. This performance is underpinned by a consistent investment in product innovation and solutions, Amway Business Owner (ABO) development and tailored go-to-market approaches that reflect the specific dynamics within the region. The ESAN region enters 2026 with a strong foundation, a clear strategic direction and is well-positioned to continue its growth trajectory.

“The 2025 results confirm that our approach is delivering results. Across the ESAN region, our business is responding to the wellbeing needs of our consumers, while providing a solid and relevant entrepreneurial opportunity to our ABOs” said Jon L. Voskuil, Managing Director Amway ESAN. “We remain focused on providing product innovations and constant support that will enable our Amway business owners and their customers to thrive in the years ahead.”

 

A resilient business model and a strengthened product portfolio

Globally, while Amway continued to advance its core strategic priorities, overall sales came in modestly below the prior year. Against this backdrop, the company made meaningful progress in areas critical to its long-term performance.

The continued relevance of Amway’s science-backed, differentiated product offering in an increasingly health-conscious consumer landscape remained the cornerstone of the business, representing 64% of global sales, with Nutrilite™ continuing to hold its position as the world’s number one selling vitamin and dietary supplements brand[5]. The company also delivered strong results in the beauty category, which grew by 8% globally, driven in part by the success of the new Artistry LongXevity™ collection. The launch of a new eSpring™ Water Purifier system generated significant demand across several markets, contributing to 25% growth in the water treatment category across launch markets.

Amway takes a holistic view of wellbeing with a focus on healthspan—helping people live in a healthy state for as long as possible.  Products and solutions are focused on everything you put in, on, and around yourself, including the supplements you take, skin care you use, the water you drink and the air you breathe.

“Amway offers solutions to some of today’s most pressing needs,” said Michael Nelson, President and Chief Executive Officer of Amway. “We combine a low-risk opportunity for business ownership, products that support health and wellbeing, and a connection to the community that so many are seeking – all rooted in our timeless values. In 2025, we focused on leveraging our long-standing strengths while pursuing new opportunities for growth. These intentional efforts position us for strong, sustainable performance in the years ahead.”

 

Looking ahead: ESAN well positioned for continued momentum

With a portfolio of holistic wellbeing solutions that address genuine consumer needs, and a motivated community, Amway ESAN is well positioned to build on its results in 2026. The region will continue to prioritise innovation, digital enablement and the development of its network as the primary drivers of sustained, long-term performance.

Amway’s 2025 Global Impact Report is available at www.amwayglobal.com/impact-report 

 

About Amway

Amway is a direct selling company committed to helping people live better lives across more than 100 countries and territories worldwide. Top-selling brands for Amway include Nutrilite™, Artistry™, eSpring™ and XS™ – all sold exclusively by Amway Business Owners. Amway is the No. 1 direct selling business in the world, according to the 2025 Direct Selling News Global 100 list[6]. For company news, visit: news.amway.eu

 

[1] https://www.directsellingnews.com/global-100-lists/

[2] Equivalent in local currency: approx. €6.6 billion, based on an exchange rate of 0.9 EUR per USD (2025).

[3] Equivalent in local currency: approx. €395 million, based on an exchange rate of 0.9 EUR per USD (2025).

[4] Equivalent in local currency: approx. €382 million, based on an exchange rate of 0.9 EUR per USD (2025).

[5]Source: GlobalData, www.gdretail.net/amway-claims.

[6] https://www.directsellingnews.com/global-100-lists/ 

© 2011 Amway Europe. All rights reserved.